The Government has published its response to the National Commission into the Regulation of AI in Healthcare, accepting all 44 recommendations and setting out a UK-wide approach to implementation.
Alongside the response, the Medicines and Healthcare products Regulatory Agency (MHRA) has opened applications for Phase 3 of AI Airlock, which will focus on post-market surveillance and the safe management of AI-enabled medical devices throughout their lifecycle.
Matt Westmore, Chief Executive of the HRA"We welcome the Government's response to the National Commission's recommendations on AI in healthcare, and the launch of Phase 3 of the MHRA's AI Airlock.
"AI has enormous potential to improve health and care. Realising those benefits will depend on ensuring that innovation develops in a way that maintains the confidence and trust of patients and the public.
"We will continue working with the MHRA and other partners to help ensure that regulatory and research governance arrangements remain clear, proportionate and connected as AI technologies develop and move into wider use."